Country of birth modifies the associations of body mass and hemoglobin A1c with office blood pressure in Middle Eastern immigrants and native Swedes

Journal of Hypertension

Volumn 32, Issue 12, 2014, Pages 2362-2370

  Bennet, Louise ^a   Nilsson, Peter M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood pressure; Cardiovascular disease; Ethnicity; Immigrant; Insulin resistance; Metabolic syndrome; Middle East

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BIRTHPLACE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMMIGRANT; IRAQ; IRAQI; LIFESTYLE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; POPULATION; PREVALENCE; PRIORITY JOURNAL; PULSE RATE; RISK ASSESSMENT; SWEDE (PEOPLE); SWEDEN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ETHNOLOGY; MIDDLE AGED; MIDDLE EAST; MIGRANT; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MIDDLE EAST; SWEDEN;

EID: 84927796471     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000345     Document Type: Article

References (50)

1. The National Board of Health and Welfare. http://www.socialstyrelsen.se/english. [Accessed 24 July 2014]
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
3. Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 57:538-545.
4. Gordon T, Garcia-Palmieri MR, Kagan A, Kannel WB, Schiffman J. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J Chronic Dis 1974; 27:329-344.
5. Beckles GL, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NT. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1986; 1:1298-1301.
6. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of noninsulin-dependent diabetes. Circulation 1990; 81:987-995.
7. Kumar BN, Selmer R, Lindman AS, Tverdal A, Falster K, Meyer HE. Ethnic differences in SCORE cardiovascular risk in Oslo, Norway. Eur J Cardiovasc Prev Rehabil 2009; 16:229-234.
8. Haas GM, Parhofer KG, Schwandt P. Prevalence of cardiovascular disease risk factors in migrants participating in the PEP Family Heart Study, Nuremberg. Int J Prev Med 2010; 1:19-28.
9. Conroy RM, PyöräläK, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
10. Statistical Central Bureau. Statistics Sweden. http://www.scb.se/en-/. [Accessed 24 July 2014]
11. Bennet L, Groop L, Lindblad U, Agardh C-D, Franks P. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes. Prim Care Diabetes 2014. doi: 10.1016/j.pcd.2014.01.002.
12. Bennet L, Agardh CD, Lindblad U. Cardiovascular disease in relation to diabetes status in immigrants from the Middle East compared to native Swedes: a cross-sectional study. BMC Public Health 2013; 13:; doi: 10.1186/1471-2458-13-1133. http://www.biomedcentral.com/1471-2458/13/1133.
13. World Medical Association. Declaration of Helsinki - ethical principles of medical research involving human subjects. 2013. http://www.wma.net/en/30publications/10policies/b3/. [Accessed 24 July 2014]
14. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462-1470.
15. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000; 151:190-198.
16. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the betacell response after oral glucose loading. Diabetes 1976; 25:241-244.
17. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of bta-cell function: the hyperbolic correction. Diabetes 2002; 51 (Suppl. 1):S212-S220.
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999.
19. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
21. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108:497-505.
22. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990; 6:1-27.
23. Tataranni PA, Christin L, Snitker S, Paolisso G, Ravussin E. Pima Indian males have lower beta-adrenergic sensitivity than Caucasian males. J Clin Endocrinol Metab 1998; 83:1260-1263.
24. Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 2000; 36:531-537.
25. Sievers ML. Myocardial infarction among southwestern American Indians. Ann Intern Med 1967; 67:800-807.
26. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990; 39:1430-1435.
27. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis 1984; 4:462-471.
28. Nelson RG, Bennett PH. Diabetic renal disease in Pima Indians. Transplant Proc 1989; 21:3913-3915.
29. McGill MJ, Donnelly R, Molyneaux L, Yue DK. Ethnic differences in the prevalence of hypertension and proteinuria in NIDDM. Diabetes Res Clin Pract 1996; 33:173-179.
30. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007; 53:897-901.
31. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004; 27:931-935.
32. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001; 50:2858-2863.
33. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986; 61:1081-1090.
34. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19:I67-77.
35. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 1997; 5:341-347.
36. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Agerelated changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13:870-877.
37. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14:177-183.
38. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92:1730-1735.
39. Saad MF, Alger SA, Zurlo F, Young JB, Bogardus C, Ravussin E. Ethnic differences in sympathetic nervous system-mediated energy expenditure. Am J Physiol 1991; 261:E789-E794.
40. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
41. Al-Tamer YY, Al-Hayali JM, Al-Ramadhan EA. Seasonality of hypertension. J Clin Hypertens (Greenwich) 2008; 10:125-129.
42. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994; 12:955-957.
43. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. A population study of ethnic variations in the angiotensinconverting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999; 17:657-664.
44. Barley J, Carter ND, Cruickshank JK, Jeffery S, Smith A, Charlett A, Webb DJ. Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure. J Hypertens 1991; 9:993-996.
45. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000; 36:878-884.
46. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
47. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013; 346:; doi: 10.1136/bmj.f1325. http://www.bmj.com/content/bmj/346/bmj.f1325.full.pdf.
48. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24h urinary sodiumexcretion and dietary surveys worldwide. BMJ Open 2013; 3:; doi: 10.1136/bmjopen-2013-003733. http://bmjopen.bmj.com/content/3/12/e003733.full.pdf+html.
49. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117-1124.
50. Yazdekhasti N, Mohammadifard N, Sarrafzadegan N, Mozaffarian D, Nazem M, Taheri M. The relationship between nut consumption and blood pressure in an Iranian adult population: Isfahan Healthy Heart Program. Nutr Metab Cardiovasc Dis 2013; 23:929-936.